Adma Biologics, Inc.
ADMA· Nasdaq
Released Nov 10, 2016, after the close
10-Q filed Nov 10, 2016, 41 days after period end · 0001193805-16-004233
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2016 | Q3 2015 | Q3 2014 | Q3 2013 |
|---|---|---|---|---|
| Revenue | $2.94M | $1.85M | $1.37M | $1.11M |
| Net Income | -$4.33M | -$5.10M | -$3.38M | -$2.69M |
| EPS Diluted | -$0.34 |
Adma Biologics, Inc. · CIK 1368514 · Engraved from SEC EDGAR
| -$0.48 |
| -$0.36 |
| -$0.46 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.